Non-genomic signaling of steroid receptors in cancer

C Thiebaut, V Vlaeminck-Guillem, O Trédan… - Molecular and Cellular …, 2021 - Elsevier
Steroid receptors (SRs) are members of the nuclear receptor family, which are ligand-
activated transcription factors. SRs regulate many physiological functions including …

[HTML][HTML] ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy

PV Elizalde, RIC Russo, MF Chervo… - Endocrine-related …, 2016 - erc.bioscientifica.com
Approximately 15–20% of breast cancers (BC) show either membrane overexpression of
ErbB-2 (MErbB-2), a member of the ErbBs family of receptor tyrosine kinases, or ERBB2 …

Molecular determinants of context-dependent progesterone receptor action in breast cancer

CR Hagan, CA Lange - BMC medicine, 2014 - Springer
The ovarian steroid hormone, progesterone, and its nuclear receptor, the progesterone
receptor, are implicated in the progression of breast cancer. Clinical trial data on the effects …

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis

L Venturutti, LV Romero, AJ Urtreger, MF Chervo… - Oncogene, 2016 - nature.com
Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a
clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence …

Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation

ME Cenciarini, CJ Proietti - Steroids, 2019 - Elsevier
The ovarian steroid hormone progesterone and its nuclear receptor, the Progesterone
Receptor (PR), play an essential role in the regulation of cell proliferation and differentiation …

[HTML][HTML] Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance

CY Wei, QX Tan, X Zhu, QH Qin, FB Zhu… - … journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Background: A new diagnostic and prognostic biomarker may be of value in cancer
diseases. Our study aimed to evaluate the CDKN1A/p21 and TGFBR2 level measurable in a …

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

S Madera, F Izzo, MF Chervo, A Dupont… - Cell Death & …, 2022 - nature.com
Triple-negative breast cancer (TNBC) is clinically defined by the absence of estrogen and
progesterone receptors and the lack of membrane overexpression or gene amplification of …

Fertility drugs and cancer: a guideline

Practice Committee of the American Society for … - Fertility and sterility, 2024 - Elsevier
Methodological limitations in studying the association between the use of fertility drugs and
cancer include the inherent increased risk of cancer in women who never conceive, the …

Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models

KA Leehy, TH Truong, LJ Mauro, CA Lange - The Journal of steroid …, 2018 - Elsevier
Estrogen is the major mitogenic stimulus of mammary gland development during puberty
wherein ER signaling acts to induce abundant PR expression. PR signaling, in contrast, is …

Increased expression of senescence markers p14ARF and p16INK4a in breast cancer is associated with an increased risk of disease recurrence and poor survival …

R Pare, JS Shin, CS Lee - Histopathology, 2016 - Wiley Online Library
Aims Breast cancer is a hormonally driven disease. Cellular senescence is an age‐related
irreversible cell cycle arrest at the G1 phase upon induction. The aim of this study was to …